Non-canonical cGAS signaling in DNA damage response

DNA 损伤反应中的非典型 cGAS 信号传导

基本信息

  • 批准号:
    10307611
  • 负责人:
  • 金额:
    $ 48.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-05 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

SUMMARY The vertebrate innate immunity relies upon a complex set of cytosolic pattern recognition receptors (PRR) to detect pathogen-derived, evolutionarily conserved molecules such as DNA. The sensing of cytosolic DNA by cyclic-GMP-AMP synthase (cGAS) activates the enzymatic synthesis of cyclic guanosine monophosphate- adenosine monophosphate (cGAMP), a cyclic dinucleotide (CDN) second messenger. cGAMP signals via its high affinity receptor protein STING, which subsequently recruits TANK-binding kinase 1 (TBK1) and interferon (IFN) regulatory factor 3 (IRF3) to stimulate the induction of type I IFNs. Although originally identified as a cytosolic sensor of foreign DNA, cGAS is also recruited to and activated by fragments of chromatin from damaged genomic DNA in the cytosol or micronuclei. Multiple convergent studies have recently highlighted the significance of cGAS in the DNA damage–induced inflammatory response and its implications for cellular senescence, tumorigenesis, and metastasis. Nothing, however, is known about whether cGAS activation in these contexts directly contributes to the maintenance of genome integrity. Recent studies in our laboratory have discovered that cGAS/cGAMP signaling triggers DNA damage response (DDR), independently of its well-characterized type I interferon pathway. These studies revealed that cGAMP-induced DDR activates cell cycle checkpoint responses that lead to G1 arrest and subsequent suppression of homology directed repair (HDR) of double-strand DNA breaks (DSB) in CRISPR/Cas9-edited mouse embryos and human and mouse cells. Interestingly, the cGAMP-induced DDR was also demonstrable in invertebrate species (oysters and starlet sea anemone) lacking interferon-based immune system, suggesting that the DNA damage surveillance mechanism of cGAMP predates its more well- known IFN-mediated immune function. The studies proposed here aim to advance these novel findings by elucidating the molecular mechanism of cGAS/cGAMP-induced DDR induction via three thematically integrated, yet independent Aims: (1) Decipher the critical signaling pathways involved in cGAMP-induced ATM activation; (2) Define the molecular mechanism of cGAS-cGAMP-induced suppression of HDR; and (3) Elucidate whether cGAMP-induced DDR potentiates the cGAS-initiated innate immunity. In summary, this work will illuminate novel aspects of the molecular and biochemical basis of cGAMP-induced activation of the apical DDR signaling kinase ATM, and increase understanding of the relationship between cGAMP-induced DDR signaling and the traditional immune function of cGAS.
总结 脊椎动物先天免疫依赖于一组复杂的胞质模式识别受体(PRR), 检测病原体衍生的、进化上保守的分子,如DNA。细胞质DNA的传感 环-GMP-AMP合酶(cGAS)激活环鸟苷一磷酸的酶促合成, 腺苷一磷酸(cGAMP),一种环二核苷酸(CDN)第二信使。cGAMP信号通过其 高亲和力受体蛋白STING,其随后募集TANK结合激酶1(TBK 1)和干扰素 (IFN)调节因子3(IRF 3)刺激I型IFN的诱导。虽然最初被确定为一个 外源DNA的胞质传感器cGAS也被来自细胞的染色质片段募集并激活 细胞质或微核中受损的基因组DNA。 最近,多项聚合研究强调了cGAS在DNA损伤诱导的细胞凋亡中的重要性。 炎症反应及其对细胞衰老、肿瘤发生和转移的影响。没什么 然而,已知在这些情况下cGAS激活是否直接有助于维持 基因组的完整性。我们实验室最近的研究发现,cGAS/cGAMP信号转导触发了 DNA损伤反应(DDR),独立于其充分表征的I型干扰素途径。这些 研究表明,cGAMP诱导的DDR激活细胞周期检查点反应,导致G1期阻滞 以及随后抑制双链DNA断裂(DSB)的同源定向修复(HDR), CRISPR/Cas9编辑的小鼠胚胎以及人类和小鼠细胞。有趣的是,cGAMP诱导的DDR 在缺乏干扰素的无脊椎动物物种(牡蛎和小海葵)中也是明显的 免疫系统,表明cGAMP的DNA损伤监测机制早于其更好的- 已知IFN介导的免疫功能。 本文提出的研究旨在通过阐明这些新发现的分子机制, cGAS/cGAMP通过三个主题集成但独立的目标诱导DDR: cGAMP诱导ATM活化的关键信号通路;(2)确定ATM活化的分子机制。 cGAS-cGAMP诱导的HDR抑制的机制;和(3)阐明cGAMP诱导的DDR是否 增强cGAS启动的先天免疫。总之,这项工作将阐明新的方面, cGAMP诱导的顶端DDR信号激酶ATM活化的分子和生物化学基础,以及 增加对cGAMP诱导的DDR信号传导与传统免疫系统之间关系的理解。 cGAS的功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nagaraj Kerur其他文献

Nagaraj Kerur的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nagaraj Kerur', 18)}}的其他基金

Non-canonical cGAS signaling in DNA damage response
DNA 损伤反应中的非典型 cGAS 信号传导
  • 批准号:
    10287373
  • 财政年份:
    2019
  • 资助金额:
    $ 48.63万
  • 项目类别:
Telomerase in choroidal neovascularization
端粒酶在脉络膜新生血管中的作用
  • 批准号:
    9808042
  • 财政年份:
    2019
  • 资助金额:
    $ 48.63万
  • 项目类别:
Telomerase in choroidal neovascularization
端粒酶在脉络膜新生血管中的作用
  • 批准号:
    10378972
  • 财政年份:
    2019
  • 资助金额:
    $ 48.63万
  • 项目类别:
Non-canonical cGAS signaling in DNA damage response
DNA 损伤反应中的非典型 cGAS 信号传导
  • 批准号:
    10064992
  • 财政年份:
    2019
  • 资助金额:
    $ 48.63万
  • 项目类别:
Non-canonical cGAS signaling in DNA damage response
DNA 损伤反应中的非典型 cGAS 信号传导
  • 批准号:
    10378366
  • 财政年份:
    2019
  • 资助金额:
    $ 48.63万
  • 项目类别:
Non-canonical NLRP3 Inflammasome Activation in Geographic Atrophy
地图样萎缩中的非典型 NLRP3 炎症小体激活
  • 批准号:
    9193873
  • 财政年份:
    2016
  • 资助金额:
    $ 48.63万
  • 项目类别:
Non-canonical NLRP3 Inflammasome Activation in Geographic Atrophy
地图样萎缩中的非典型 NLRP3 炎症小体激活
  • 批准号:
    9323160
  • 财政年份:
    2016
  • 资助金额:
    $ 48.63万
  • 项目类别:
Non-canonical NLRP3 Inflammasome Activation in Geographic Atrophy
地图样萎缩中的非典型 NLRP3 炎症小体激活
  • 批准号:
    8679129
  • 财政年份:
    2014
  • 资助金额:
    $ 48.63万
  • 项目类别:
Non-canonical NLRP3 Inflammasome Activation in Geographic Atrophy
地图样萎缩中的非典型 NLRP3 炎症小体激活
  • 批准号:
    8815324
  • 财政年份:
    2014
  • 资助金额:
    $ 48.63万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.63万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了